TrialJAMA network open2024

Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.

Andreas Stahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.